Annex 22 and AI Governance for GMP: Human Review, Model Monitoring, and Change Control
Meet EU Annex 22 AI governance requirements in GMP — covering human review, model monitoring, change control, CSV vs CSA, GAMP®5, and inspection readiness for AI/ML systems.
Instructor
Carolyn Troiano
FDA Compliance & Computer System Validation Consultant
What You'll Learn
About the event
About this event
Providing safe and effective FDA-regulated products is in the best interests of all those involved in their development, manufacturing, testing, and distribution. With newer technologies such as AI in the mix, it means opportunity for greater efficiency and efficacy, but also poses more challenges for companies that develop, test, and support software applications in the life science industries. AI can hallucinate, and show bias and performance drift. The human expert must be able to critically assess the output and make the judgment calls for better decisions, quality, and compliance, and to optimize ROI.
In this webinar, you will learn just how AI, ML and LLMs, such as ChatGPT can increase efficiency and effectiveness of software development life cycle (SDLC) activities, enabling the delivery and support of computer solutions and new innovative products that will drive industry over the coming years. In particular, you'll learn about the need for human review by the expert who applies critical thinking to ensure better outcomes, decisions, quality, patient safety, compliance, and ROI.
Artificial Intelligence (AI), Machine Learning (ML) and Large Language Models (LLMs), such as ChatGPT are beginning to find a presence at life science companies. While life science companies tend to lag behind other markets in using these technologies, they are catching up and we are seeing much more activity related to AI use in software applications used to develop, produce, test, and manage life science products with quality and compliance.
As the pace of technological innovation and evolution becomes more intense, there is a critical need for computer system validation, 21 CFR Part 11 (Electronic Records and Electronic Signatures) compliance, and data integrity assurance to continue in environments where artificial intelligence (AI) and machine learning (ML) are becoming more prevalent. In addition, the European Union (EU) has issued Annex 22 for AI governance.
AI can hallucinate, and show bias and performance drift. AI solutions need human guardrails — the experts who can evaluate output and, based on broad and deep expertise, make the right judgment calls for better outcomes and quality decisions. Without this safeguard, we may never achieve the great potential in ensuring quality, compliance, and real ROI from these technological innovations.
We'll cover all key aspects of EU Annex 22 as it applies to Human Review, Model Monitoring, and Change Control. We'll provide an overview of validation, including CSV and Computer Software Assurance (CSA), and the latest GAMP®5, 2nd Edition that aligns with CSA. We'll walk you through the Software Validation and Maintenance approach that will bring clarity to what FDA is looking for in terms of compliance.
Code: FDB2849
Curriculum
Requirements
- Working in FDA-regulated industries (pharmaceutical, medical device, biotech, tobacco)
- Involvement in planning, executing, or managing computer system validation or AI implementations
- Applicable to IT analysts, QA/QC managers, regulatory affairs, clinical data, and compliance roles
Who Should Attend
Information technology analysts, developers and testers; QC/QA managers and analysts; analytical chemists; compliance and audit managers; laboratory managers; automation analysts and managers; manufacturing and supply chain specialists; regulatory affairs and submissions specialists; clinical data analysts and managers; computer system validation specialists; GMP training specialists; business stakeholders responsible for computer system validation planning, execution, reporting, compliance, maintenance and audit; consultants and auditors working in the life sciences industry. This webinar will also benefit vendors and software development companies supporting life science industries.
Areas Covered
Meet Your Instructor
Carolyn Troiano
FDA Compliance & Computer System Validation Consultant
Carolyn Troiano has more than 45 years of experience in computer system validation in the pharmaceutical, medical device, biotechnology, tobacco, and other FDA-regulated industries. She is currently an independent consultant, advising companies on FDA compliance, Computer System Validation (CSV), and large-scale IT system implementation projects. Carolyn participated in the FDA/Industry Partnership to develop 21 CFR Part 11, the FDA's Guidance for Electronic Records and Electronic Signatures. During her career she has provided training on CSV, 21 CFR Part 11, Data Integrity, and many other compliance topics of interest to the life science industries.
Event Details
Format
Recorded Webinar
Duration
1.5 hours
Certificate
Included
Access
Lifetime
Related Events
Digital Quality Metrics and AI/ML Analytics: Building a Continuous-Improvement Framework that Aligns with Regulatory Expectations
Learn how AI/ML and real-time digital quality metrics build a continuous-improvement framework aligned with FDA regulatory expectations, 21 CFR Part 11, and GAMP®5.
Carolyn Troiano
AI in GMP: What the FDA Is Already Expecting - Before You Ask
FDA already expects GMP compliance for AI systems. Learn how existing validation, data integrity, and oversight rules apply—before regulators come calling.
Dr. Ginette Collazo
HPLC Analytical Method Development and Validation
Master HPLC instrument and method validation to meet US EPA and FDA requirements for pharmaceutical analysis.
Dr. John C. Fetzer